|
WO1999003483A1
(en)
|
1997-07-15 |
1999-01-28 |
University Technology Corporation |
Use of neurotoxin therapy for treatment of urologic and related disorders
|
|
US7455845B2
(en)
|
1997-07-15 |
2008-11-25 |
The Regents Of The University Of Colorado |
Use of neurotoxin therapy for treatment of urologic and related disorders related to lowering elevated bladder pressure
|
|
US7470431B2
(en)
*
|
1997-07-15 |
2008-12-30 |
The Regents Of The University Of Colorado |
Use of neurotoxin therapy for treatment of urological-neurological disorders associated with prostate cancer
|
|
US9066943B2
(en)
|
1997-07-15 |
2015-06-30 |
The Regents Of The University Of Colorado |
Use of botulinum toxin therapy for treatment of urological neurological conditions
|
|
US7449192B2
(en)
|
1997-07-15 |
2008-11-11 |
The Regents Of The University Of Colorado |
Use of neurotoxin therapy for treatment of urologic and related disorders related to neurogenic bladder dysfunction
|
|
TR200103388T2
(tr)
*
|
1999-04-01 |
2002-05-21 |
Heeling Sports Limited |
Heeling aleti ve yöntemi.
|
|
DE19925739A1
(de)
*
|
1999-06-07 |
2000-12-21 |
Biotecon Ges Fuer Biotechnologische Entwicklung & Consulting Mbh |
Therapeutikum mit einem Botulinum-Neurotoxin
|
|
US7838008B2
(en)
*
|
1999-12-07 |
2010-11-23 |
Allergan, Inc. |
Methods for treating diverse cancers
|
|
US7838007B2
(en)
*
|
1999-12-07 |
2010-11-23 |
Allergan, Inc. |
Methods for treating mammary gland disorders
|
|
US6524580B1
(en)
|
2000-02-15 |
2003-02-25 |
Allergan Sales, Inc. |
Method for treating thyroid disorders
|
|
US6821520B2
(en)
|
2000-02-15 |
2004-11-23 |
Allergan, Inc. |
Clostridial toxin therapy for Hashimoto's thyroiditis
|
|
US6358513B1
(en)
|
2000-02-15 |
2002-03-19 |
Allergan Sales, Inc. |
Method for treating Hashimoto's thyroiditis
|
|
US6773711B2
(en)
|
2000-02-15 |
2004-08-10 |
Allergan, Inc. |
Botulinum toxin therapy for Hashimoto's thyroiditis
|
|
US20040170665A1
(en)
*
|
2000-06-02 |
2004-09-02 |
Allergan, Inc. |
Intravitreal botulinum toxin implant
|
|
US20050214327A1
(en)
*
|
2000-06-02 |
2005-09-29 |
Allergan, Inc. |
Neurotoxin-containing suppositories and related methods
|
|
US20040033241A1
(en)
*
|
2000-06-02 |
2004-02-19 |
Allergan, Inc. |
Controlled release botulinum toxin system
|
|
US6306403B1
(en)
*
|
2000-06-14 |
2001-10-23 |
Allergan Sales, Inc. |
Method for treating parkinson's disease with a botulinum toxin
|
|
US7691983B2
(en)
*
|
2000-07-21 |
2010-04-06 |
Allergan, Inc. |
Chimera botulinum toxin type E
|
|
US6903187B1
(en)
*
|
2000-07-21 |
2005-06-07 |
Allergan, Inc. |
Leucine-based motif and clostridial neurotoxins
|
|
US20040219619A1
(en)
*
|
2000-07-21 |
2004-11-04 |
Ester Fernandez-Salas |
Methods of identifying compounds that alter toxin persistence and/or protease activity
|
|
US7491799B2
(en)
*
|
2000-07-21 |
2009-02-17 |
Allergan, Inc. |
Modified botulinum neurotoxins
|
|
GB0029125D0
(en)
*
|
2000-11-29 |
2001-01-10 |
Specialistkliniken I Varberg H |
Novel treatment
|
|
JP4707254B2
(ja)
*
|
2001-04-24 |
2011-06-22 |
クミアイ化学工業株式会社 |
粒状組成物及びその製造方法
|
|
DE60239134D1
(de)
*
|
2001-07-10 |
2011-03-24 |
Astellas Pharma Inc |
Pharmazeutische zusammensetzung enthaltend quinuclidin-3'-yl 1-phenyl-1,2,3,4,-tetrahydroisoquinolin-2-carboxylat zur behandlung der interstitiellen cystitis und/oder der abakteriellen prostatitis
|
|
US6984375B2
(en)
*
|
2001-08-03 |
2006-01-10 |
Allergan, Inc. |
Nuclei density and nuclei area methods for determining effects of a botulinum toxin on muscles
|
|
US20100104631A1
(en)
*
|
2001-08-13 |
2010-04-29 |
Lipella Pharmaceuticals Inc. |
Method of treatment for bladder dysfunction
|
|
US8110217B2
(en)
*
|
2001-08-13 |
2012-02-07 |
University Of Pittsburgh |
Sphingomyelin liposomes for the treatment of hyperactive bladder disorders
|
|
WO2003015698A2
(en)
*
|
2001-08-13 |
2003-02-27 |
University Of Pittsburgh |
Application of lipid vehicles and use for drug delivery
|
|
US7255866B2
(en)
|
2001-09-17 |
2007-08-14 |
Allergan, Inc. |
Botulinum toxin therapy for fibromyalgia
|
|
US6623742B2
(en)
|
2001-09-17 |
2003-09-23 |
Allergan, Inc. |
Methods for treating fibromyalgia
|
|
ES2401570T3
(es)
|
2001-11-15 |
2013-04-22 |
Phytotox Limited |
Composiciones farmacéuticas que contienen 3,4-propinoperhidropurinas y usos de las mismas para bloquear la transmisión neuronal
|
|
US7763663B2
(en)
*
|
2001-12-19 |
2010-07-27 |
University Of Massachusetts |
Polysaccharide-containing block copolymer particles and uses thereof
|
|
US6688311B2
(en)
|
2002-03-14 |
2004-02-10 |
Allergan, Inc. |
Method for determining effect of a clostridial toxin upon a muscle
|
|
US7140371B2
(en)
|
2002-03-14 |
2006-11-28 |
Allergan, Inc. |
Surface topography method for determining effects of a botulinum toxin upon a muscle and for comparing botulinum toxins
|
|
US7691394B2
(en)
*
|
2002-05-28 |
2010-04-06 |
Botulinum Toxin Research Associates, Inc. |
High-potency botulinum toxin formulations
|
|
US6776991B2
(en)
*
|
2002-06-26 |
2004-08-17 |
Allergan, Inc. |
Methods for treating priapism
|
|
US20040067235A1
(en)
*
|
2002-07-29 |
2004-04-08 |
Rajiv Doshi |
Methods for the use of neurotoxin in the treatment of urologic disorders
|
|
US20040086532A1
(en)
*
|
2002-11-05 |
2004-05-06 |
Allergan, Inc., |
Botulinum toxin formulations for oral administration
|
|
US7238357B2
(en)
*
|
2002-11-05 |
2007-07-03 |
Allergan, Inc. |
Methods for treating ulcers and gastroesophageal reflux disease
|
|
GB2398636A
(en)
*
|
2003-02-21 |
2004-08-25 |
Ipsen Ltd |
Method for determining the quantity of pre-synaptic neuromuscular blocking substance contained in a sample
|
|
US8071550B2
(en)
*
|
2003-03-03 |
2011-12-06 |
Allergan, Inc. |
Methods for treating uterine disorders
|
|
ZA200506715B
(en)
*
|
2003-03-06 |
2007-05-30 |
Botulinum Toxin Res Ass Inc |
Treatment of sinusitis related chronic facial pain and headache with botulinum toxin
|
|
CA2518155A1
(en)
*
|
2003-03-06 |
2004-09-16 |
Botulinum Toxin Research Associates, Inc. |
Treatment of chronic chalazion and hordeolum with botulinum toxin
|
|
US7422753B2
(en)
*
|
2003-04-25 |
2008-09-09 |
Allergan, Inc. |
Methods for treating trichotillomania
|
|
US7396535B2
(en)
*
|
2003-04-25 |
2008-07-08 |
Ackerman Alan H |
Therapy for obsessive compulsive head banging
|
|
US7393538B2
(en)
*
|
2003-04-25 |
2008-07-01 |
Ackerman Alan H |
Clostridial toxin treatment for dermatillomania
|
|
US7390496B2
(en)
*
|
2003-04-25 |
2008-06-24 |
Allergan, Inc. |
Therapeutic treatments for repetitive hand washing
|
|
US7393537B2
(en)
*
|
2003-04-25 |
2008-07-01 |
Allergan, Inc. |
Botulinum toxin for treatment of obsessive compulsive finger biting disorder
|
|
US6838434B2
(en)
*
|
2003-05-02 |
2005-01-04 |
Allergan, Inc. |
Methods for treating sinus headache
|
|
US7220422B2
(en)
|
2003-05-20 |
2007-05-22 |
Allergan, Inc. |
Methods and compositions for treating eye disorders
|
|
US20040253274A1
(en)
*
|
2003-06-11 |
2004-12-16 |
Allergan, Inc. |
Use of a clostridial toxin to reduce appetite
|
|
US20050013850A1
(en)
*
|
2003-07-15 |
2005-01-20 |
Caers Jan K. |
Device to assist hyperhydrosis therapy
|
|
US7354740B2
(en)
|
2003-09-25 |
2008-04-08 |
Allergan, Inc. |
Animal product free system and process for purifying a botulinum toxin
|
|
US8734810B2
(en)
|
2003-10-29 |
2014-05-27 |
Allergan, Inc. |
Botulinum toxin treatments of neurological and neuropsychiatric disorders
|
|
US8609112B2
(en)
|
2003-10-29 |
2013-12-17 |
Allergan, Inc. |
Botulinum toxin treatments of depression
|
|
US8617572B2
(en)
*
|
2003-10-29 |
2013-12-31 |
Allergan, Inc. |
Botulinum toxin treatments of depression
|
|
US8609113B2
(en)
|
2003-10-29 |
2013-12-17 |
Allergan, Inc. |
Botulinum toxin treatments of depression
|
|
US7437194B2
(en)
*
|
2003-10-31 |
2008-10-14 |
Medtronic, Inc. |
Stimulating the prostate gland
|
|
US20050096549A1
(en)
*
|
2003-10-31 |
2005-05-05 |
Medtronic, Inc. |
Techniques for transperineal delivery of a denervating agent to the prostate gland
|
|
US20050096629A1
(en)
*
|
2003-10-31 |
2005-05-05 |
Medtronic, Inc. |
Techniques for transurethral delivery of a denervating agent to the prostate gland
|
|
US20050096550A1
(en)
*
|
2003-10-31 |
2005-05-05 |
Medtronic, Inc. |
Techniques for transrectal delivery of a denervating agent to the prostate gland
|
|
US7172764B2
(en)
*
|
2003-11-17 |
2007-02-06 |
Allergan, Inc. |
Rescue agents for treating botulinum toxin intoxications
|
|
GB0328060D0
(en)
|
2003-12-04 |
2004-01-07 |
Sod Conseils Rech Applic |
Botulinum toxin treatment
|
|
US20050129677A1
(en)
*
|
2003-12-10 |
2005-06-16 |
Shengwen Li |
Lipid rafts and clostridial toxins
|
|
US20050148935A1
(en)
*
|
2003-12-29 |
2005-07-07 |
Rozalina Dimitrova |
Botulinum toxin injection guide
|
|
US9211248B2
(en)
|
2004-03-03 |
2015-12-15 |
Revance Therapeutics, Inc. |
Compositions and methods for topical application and transdermal delivery of botulinum toxins
|
|
BRPI0510759A
(pt)
*
|
2004-05-07 |
2007-11-20 |
Phytotox Ltd |
método de facilitar a cura de um ferimento
|
|
BRPI0510760A
(pt)
*
|
2004-05-07 |
2007-11-20 |
Phytotox Ltd |
método para administrar a um paciente uma composição, composição tópica, e, emplastro
|
|
WO2006130161A2
(en)
*
|
2004-07-21 |
2006-12-07 |
The Cornell Research Foundation, Inc. |
Therapeutic compounds derived from spider venom and their method of use
|
|
US20060024794A1
(en)
*
|
2004-07-30 |
2006-02-02 |
Shengwen Li |
Novel methods for production of di-chain botulinum toxin
|
|
EP1776137B1
(en)
|
2004-08-04 |
2014-11-26 |
Ipsen Biopharm Limited |
Pharmaceutical composition containing botulinum neurotoxin a2
|
|
ES2526913T3
(es)
|
2004-08-04 |
2015-01-16 |
Ipsen Biopharm Limited |
Composición farmacéutica que contiene neurotoxina 2 botulínica
|
|
US7429386B2
(en)
|
2004-09-03 |
2008-09-30 |
Allergan, Inc. |
Stretch mark treatment
|
|
US7179474B2
(en)
*
|
2004-09-03 |
2007-02-20 |
Allergan, Inc. |
Methods for treating a buttock deformity
|
|
US7727537B2
(en)
|
2005-02-14 |
2010-06-01 |
Dpm Therapeutics Corp. |
Stabilized compositions for topical administration and methods of making same
|
|
US7419675B2
(en)
*
|
2005-05-26 |
2008-09-02 |
Allergan, Inc. |
Method for treating peritoneal adhesions
|
|
US8439867B2
(en)
*
|
2005-06-07 |
2013-05-14 |
David R. Staskin |
Injection guidance system and method
|
|
US20070038089A1
(en)
*
|
2005-06-29 |
2007-02-15 |
Olympus Medical Systems Corp. |
Transurethral diagnostic method and treatment method using ultrasonic endoscope
|
|
JP5368793B2
(ja)
|
2005-07-18 |
2013-12-18 |
ユニバーシティ オブ マサチューセッツ ロウエル |
ナノエマルジョンを製造および使用するための組成物および方法
|
|
US7910116B2
(en)
*
|
2005-08-24 |
2011-03-22 |
Allergan, Inc. |
Use of a botulinum toxin to improve gastric emptying and/or to treat GERD
|
|
JP5815915B2
(ja)
*
|
2005-10-11 |
2015-11-17 |
ユニバーシティー オブ ピッツバーグ − オブ ザ コモンウェルス システム オブ ハイヤー エデュケーション |
過活動膀胱障害の治療のためのスフィンゴミエリンリポソーム
|
|
WO2008045107A2
(en)
|
2005-12-01 |
2008-04-17 |
University Of Massachusetts Lowell |
Botulinum nanoemulsions
|
|
US9486408B2
(en)
|
2005-12-01 |
2016-11-08 |
University Of Massachusetts Lowell |
Botulinum nanoemulsions
|
|
US20090312696A1
(en)
*
|
2005-12-28 |
2009-12-17 |
Copa Vincent G |
Devices, Systems, and Related Methods for Delivery of Fluid to Tissue
|
|
WO2007106874A2
(en)
*
|
2006-03-14 |
2007-09-20 |
Autocraft Industries, Inc. |
Improved wheelchair
|
|
US7794386B2
(en)
|
2006-03-15 |
2010-09-14 |
Allergan, Inc. |
Methods for facilitating weight loss
|
|
US7811586B2
(en)
*
|
2006-05-02 |
2010-10-12 |
Allergan, Inc. |
Methods for alleviating testicular pain
|
|
WO2008030638A2
(en)
*
|
2006-05-16 |
2008-03-13 |
Mayo Foundation For Medical Education And Research |
Use of dmso and botulinum toxin therapy for urinary incontinence and related disorders
|
|
US10792344B2
(en)
|
2006-06-29 |
2020-10-06 |
Merz Pharma Gmbh & Co. Kgaa |
High frequency application of botulinum toxin therapy
|
|
AR061669A1
(es)
|
2006-06-29 |
2008-09-10 |
Merz Pharma Gmbh & Co Kgaa |
Aplicacion de alta frecuencia de terapia con toxina botulinica
|
|
US20080092910A1
(en)
*
|
2006-10-18 |
2008-04-24 |
Allergan, Inc. |
Apparatus and method for treating obesity using neurotoxins in conjunction with bariatric procedures
|
|
US20080113051A1
(en)
*
|
2006-11-13 |
2008-05-15 |
Allergan, Inc. |
Methods for alleviating tattoo pain
|
|
SG179457A1
(en)
|
2006-12-01 |
2012-04-27 |
Anterios Inc |
Peptide nanoparticles and uses therefor
|
|
CN101848702B
(zh)
|
2006-12-01 |
2013-07-17 |
安特里奥公司 |
两亲实体纳米粒子
|
|
JP2010519211A
(ja)
*
|
2007-02-15 |
2010-06-03 |
アラーガン、インコーポレイテッド |
膀胱もしくは前立腺障害または多汗症を処置するためのボツリヌス毒素および酵素の使用
|
|
CN101765423B
(zh)
|
2007-05-31 |
2014-08-06 |
安特里奥公司 |
核酸纳米粒子和其用途
|
|
JP2011514308A
(ja)
|
2007-10-23 |
2011-05-06 |
アラーガン、インコーポレイテッド |
改変クロストリジウム毒素を用いる泌尿生殖器神経学的障害の治療方法
|
|
US8470337B2
(en)
*
|
2008-03-13 |
2013-06-25 |
Allergan, Inc. |
Therapeutic treatments using botulinum neurotoxin
|
|
CN105147608B
(zh)
*
|
2008-06-26 |
2019-12-10 |
安特里奥公司 |
真皮递送
|
|
WO2010096134A1
(en)
|
2008-12-04 |
2010-08-26 |
Botulinum Toxin Research Associates, Inc. |
Extended length botulinum toxin formulation for human or mammalian use
|
|
CA2752506A1
(en)
*
|
2008-12-15 |
2010-06-24 |
Protox Therapeutics Inc. |
Method for treating prostatitis utilizing modified pore-forming protein proaerolysin
|
|
US20100166739A1
(en)
*
|
2008-12-30 |
2010-07-01 |
Lipella Paharmaceuticals Inc. |
Methods and Compositions for Diagnosing Urological Disorders
|
|
US8133491B1
(en)
|
2009-01-30 |
2012-03-13 |
The University Of Toledo |
Compositions and methods for treatment of hyperplastic disorders
|
|
CA2754423A1
(en)
|
2009-03-06 |
2010-09-10 |
Allergan, Inc. |
Clostridial toxin to improve ejaculate
|
|
US20100303791A1
(en)
*
|
2009-05-29 |
2010-12-02 |
Allergan, Inc. |
Methods of Treating Chronic Neurogenic Inflammation Using Glucagon Like Hormone Retargeted Endopepidases
|
|
US20100303794A1
(en)
*
|
2009-05-29 |
2010-12-02 |
Allergan, Inc. |
Methods of Treating Urogenital-Neurological Disorders Using Glucagon Like Hormone Retargeted Endopepidases
|
|
US20100303756A1
(en)
*
|
2009-05-29 |
2010-12-02 |
Allergan, Inc. |
Methods of Treating Urogenital-Neurological Disorders Using Interleukin Retargeted Endopepidases
|
|
US20100303789A1
(en)
*
|
2009-05-29 |
2010-12-02 |
Allergan, Inc. |
Methods of Treating Chronic Neurogenic Inflammation Using Neurotrophin Retargeted Endopepidases
|
|
US20100303798A1
(en)
*
|
2009-05-29 |
2010-12-02 |
Allergan, Inc. |
Methods of Treating Urogenital-Neurological Disorders Using Neurotrophin Retargeted Endopepidases
|
|
US20100303783A1
(en)
*
|
2009-05-29 |
2010-12-02 |
Allergan, Inc. |
Methods of Treating Urogenital-Neurological Disorders Using Tachykinin Retargeted Endopepidases
|
|
US8198229B2
(en)
*
|
2009-05-29 |
2012-06-12 |
Allergan, Inc. |
Methods of treating urogenital-neurological disorders using galanin retargeted endopepidases
|
|
US20100303788A1
(en)
*
|
2009-05-29 |
2010-12-02 |
Allergan, Inc. |
Methods of Treating Chronic Neurogenic Inflammation Using Galanin Retargeted Endopepidases
|
|
US8147848B2
(en)
|
2009-08-26 |
2012-04-03 |
Allergan, Inc. |
Method for treating premature ejaculation with a botulinum neurotoxin
|
|
EP2482838A4
(en)
|
2009-09-30 |
2013-04-10 |
Toxcure Inc |
USE OF BOTULINUM NEUROTOXIN FOR THE TREATMENT OF SUBSTANCE DEPENDENCE
|
|
WO2012024269A2
(en)
|
2010-08-18 |
2012-02-23 |
Medtronic, Inc. |
Urgency therapy with neuromodulation and c-afferent nerve desensitization
|
|
EP2672958A1
(en)
|
2011-02-08 |
2013-12-18 |
Halozyme, Inc. |
Composition and lipid formulation of a hyaluronan-degrading enzyme and the use thereof for treatment of benign prostatic hyperplasia
|
|
WO2012112426A1
(en)
*
|
2011-02-14 |
2012-08-23 |
Allergan, Inc. |
Arginine vasopressin retargeted clostridial endopeptidases for use in treating benign prostatic hyperplasia
|
|
US8992941B2
(en)
|
2011-07-08 |
2015-03-31 |
Allergan, Inc. |
Method for treatment of esophageal spasm
|
|
US20140140983A1
(en)
|
2011-07-08 |
2014-05-22 |
Allergan, Inc. |
Method for treatment of autonomic nervous system disorders
|
|
WO2013010100A1
(en)
|
2011-07-14 |
2013-01-17 |
Allergan, Inc. |
Methods for treatment of incontinence associated with sexual activity
|
|
CN103702681A
(zh)
|
2011-07-20 |
2014-04-02 |
阿勒根公司 |
用于治疗脂肪沉积的方法
|
|
US20130171122A1
(en)
*
|
2011-12-29 |
2013-07-04 |
Allergan, Inc. |
Endopeptidase and neurotoxin combination treatment of bladder disorders
|
|
ES2821098T3
(es)
*
|
2012-04-08 |
2021-04-23 |
Urogen Pharma Ltd |
Preparaciones de hidrogel térmico reversible para su uso en el tratamiento de trastornos del urotelio
|
|
US9393291B2
(en)
|
2012-04-12 |
2016-07-19 |
Botulinum Toxin Research Associates, Inc. |
Use of botulinum toxin for the treatment of cerebrovascular disease, renovascular and retinovascular circulatory beds
|
|
US10149893B2
(en)
|
2013-09-24 |
2018-12-11 |
Allergan, Inc. |
Methods for modifying progression of osteoarthritis
|
|
US9901627B2
(en)
|
2014-07-18 |
2018-02-27 |
Revance Therapeutics, Inc. |
Topical ocular preparation of botulinum toxin for use in ocular surface disease
|
|
US11484580B2
(en)
|
2014-07-18 |
2022-11-01 |
Revance Therapeutics, Inc. |
Topical ocular preparation of botulinum toxin for use in ocular surface disease
|
|
CA2973310C
(en)
*
|
2015-02-03 |
2023-03-14 |
Hoganas Ab (Publ) |
Powder metal composition for easy machining
|
|
MA45492A
(fr)
|
2016-06-23 |
2019-05-01 |
Hopitaux Paris Assist Publique |
Vecteurs viraux pour le traitement de l'hyperactivité vésicale neurogène
|
|
WO2018038301A1
(en)
|
2016-08-26 |
2018-03-01 |
Hugel Inc. |
Stabilized liquid formulation of botulinum toxin and preparation method thereof
|
|
PL3432916T3
(pl)
|
2016-09-13 |
2020-04-30 |
Allergan, Inc. |
Niebiałkowo stabilzowane kompozycje toksyny clostridium
|
|
CA3044219A1
(en)
|
2016-11-21 |
2018-05-24 |
Eirion Therapeutics, Inc. |
Transdermal delivery of large agents
|
|
EP3470054B1
(en)
|
2017-10-11 |
2023-09-20 |
Hugel Inc. |
Microstructure formulation techniques for botulinum toxin
|
|
US10525111B2
(en)
|
2017-10-12 |
2020-01-07 |
Hugel, Inc. |
Microstructure formulation techniques for botulinum toxin
|
|
US10792400B2
(en)
|
2017-10-12 |
2020-10-06 |
Hugel Inc. |
Microstructure formulation techniques for botulinum toxin
|
|
RU2687106C1
(ru)
*
|
2017-12-19 |
2019-05-07 |
Федеральное государственное бюджетное образовательное учреждение высшего образования "Волгоградский государственный медицинский университет" Министерства здравоохранения Российской Федерации ФГБОУ ВО ВолгГМУ МЗ РФ |
Способ лечения синдрома гиперактивного мочевого пузыря
|
|
LT3660509T
(lt)
|
2018-11-29 |
2022-05-10 |
Hugel Inc. |
Ląstelių panaudojimu paremtas būdas botulino toksino aktyvumui nustatyti
|
|
CN110935009B
(zh)
*
|
2019-12-24 |
2023-07-11 |
云南南诏药业有限公司 |
科博肽制剂在制备治疗痔疮药物中的应用
|
|
RU2768606C1
(ru)
*
|
2021-04-16 |
2022-03-24 |
Федеральное государственное бюджетное учреждение "Национальный медицинский исследовательский центр колопроктологии имени А.Н. Рыжих" Министерства здравоохранения Российской Федерации |
Способ комбинированного хирургического лечения хронической анальной трещины со спазмом сфинктера методом иссечения трещины в сочетании с инъекцией ботулинического токсина типа А в дозировке 40 ЕД во внутренний анальный сфинктер под ультразвуковой навигацией
|